Christopher Lathan, MD, Chief Clinical Access Officer, Dana-Farber Cancer Institute

● Dr. Christopher Lathan is the Chief Clinical Access Officer at Dana-Farber, founding
Director of the Cancer Care Access Program and a clinical oncologist focusing on lung
cancer.
● His research is centered on the effects of race, class, and access to care in cancer
outcomes, including racial disparities in lung cancer treatment, differences in access
to precision medicine by race and social class and equitable distribution of new
treatment across historically marginalized populations.
● Dr. Lathan aims to bridge the gap between research in disparities and the realities of
patient care by developing interventions to increase access to high quality care,
developed in part through community engagement.